Previous 10 | Next 10 |
Gainers: Sesen Bio (NASDAQ:SESN) +43%, Radius Health (NASDAQ:RDUS) +29%, Valneva SE (NASDAQ:VALN) +15%, Olema Pharmaceuticals (NASDAQ:OLMA) +15%, First Wave BioPharma (NASDAQ:FWBI) +6%. Losers: ATI Physical Therapy (NYSE:ATIP) -20%, HCW Biologics (...
The darling of Wall Street received a downgrade from Deutsche Bank downgraded Netflix (NASDAQ:NFLX) to hold from buy and maintained its 12-month price target of $590, which is 7% below where the stock closed Tuesday. However, Wall Street is still optimistic with Facebook (NASDAQ:FB) and other...
Study met both primary endpoints in patients with ER+/HER2- advanced or mBC Elacestrant becomes the first oral SERD with positive topline results in pivotal study as a monotherapy versus SoC for the treatment of ER+/HER2- advanced or mBC Elacestrant extended PFS in the overall p...
ATOM study met the primary endpoint of change in lumbar spine bone mineral density at 12 months (p-value < 0.0001) Study also met secondary endpoints relating to bone mineral density changes in lumbar spine at 6 months as well as at hip and femoral neck at 12 months Safety pr...
TYMLOS® label: significant update to the Mechanism of Action (MOA) section Label change aligns with strategic focus on postmenopausal women at high risk of fracture Danielle Holtschlag joins as Head of Sales, bringing 20 years of experience to the team Added ~3,000 new ...
Radius Health, Inc. (RDUS) Q2 2021 Results Conference Call August 05, 2021 08:30 AM ET Company Participants Ethan Holdaway - Head, IR Kelly Martin - President and CEO Jim Chopas - Principal Finance and Accounting Officer Sal Grausso - Chief Commercial Officer Chhaya Shah - Chief Business Offi...
Image source: The Motley Fool. Radius Health (NASDAQ: RDUS) Q2 2021 Earnings Call Aug 05, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Radius Health (RDUS) Q2 2021 Earnings Call Transcript
The following slide deck was published by Radius Health, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Radius Health, Inc. 2021 Q2 - Results - Earnings Call Presentation
Repositioned the Company to create meaningful P+L operating leverage Dramatic improvement in Adj. EBITDA performance: ($6) million in Q2, 2021 vs. ($29) million in Q2, 2020 FY 2021 guidance: reiterate Adj. EBITDA of $10 million while reducing TYMLOS revenue from $250 to $240 milli...
FDA Type C meeting minutes provide clarity on the Phase 2/3 study design for RAD011 505(b)(2) regulatory strategy: acceptable approach upon completion of PK & food effect studies Based on results, a single well controlled study could serve as the basis for marketing approval...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...